Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

STI 571 (GLIVEC) in the Treatment of Philadelphia-chromosome Positive and/or BCR/ABL Rearranged Adult Acute Lymphoblastic Leukemia. GIMEMA LAL 0201.

Authors not listed

Gruppo Italiano Malattie EMatologiche dell'Adulto · 2001

Abstract

This proposal, developed in the framework of the GIMEMA, will permit: * to evaluate the activity and toxicity of imatinib in the treatment of Ph+ acute lymphoblastic leukemia; * to evaluate the molecular response to the treatment, and to monitor the molecular status of remission in all cases achieving or not a molecular response. The GIMEMA has activated a network to centralize all biological samples (bone marrow and peripheral blood) at diagnosis from all new ALL patients. This will permit to identify, in particular, Ph + and/or BCR/ABL + cases within 5 days from diagnosis, thus permitting to treat these patients according to different programs on the basis of the presence of Ph chromosome.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Anonymous. (2001). STI 571 (GLIVEC) in the Treatment of Philadelphia-chromosome Positive and/or BCR/ABL Rearranged Adult Acute Lymphoblastic Leukemia. GIMEMA LAL 0201. <em>Gruppo Italiano Malattie EMatologiche dell'Adulto</em>. https://clinicaltrials.gov/study/NCT00376467
Vancouver
Anonymous. STI 571 (GLIVEC) in the Treatment of Philadelphia-chromosome Positive and/or BCR/ABL Rearranged Adult Acute Lymphoblastic Leukemia. GIMEMA LAL 0201. Gruppo Italiano Malattie EMatologiche dell'Adulto. 2001.
BibTeX
@misc{anon2001STIGLI, title = {STI 571 (GLIVEC) in the Treatment of Philadelphia-chromosome Positive and/or BCR/ABL Rearranged Adult Acute Lymphoblastic Leukemia. GIMEMA LAL 0201.}, author = {Anonymous}, journal = {Gruppo Italiano Malattie EMatologiche dell'Adulto}, year = {2001}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings